{"transactions":[{"id":1546322,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":92175,"kind":"person","name":"Currie Graeme Martin","position":1,"cik":"0001965006","reported_name":"Currie Graeme Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-06T01:45:13.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":5938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), on March 1, 2024, was $8.13 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option award (the \"Option\") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The Option fully vested upon issuance and became exercisable on March 1, 2024."}],"balance_after":5938,"derivative":{"exercise_price":8.13,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":5938},"source":{"system":"sec-edgar","filing":"0001213900-24-030959","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1841330/000121390024030959/ownership.xml","form_type":"4/A","original_submission_date":"2024-03-01"}},{"id":1605745,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":92175,"kind":"person","name":"Currie Graeme Martin","position":1,"cik":"0001965006","reported_name":"Currie Graeme Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T02:45:23.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":5938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award (the \"Option\") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The Option fully vested upon issuance and became exercisable on March 1, 2024."}],"balance_after":5938,"derivative":{"exercise_price":8.34,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":5938},"source":{"system":"sec-edgar","filing":"0001213900-24-019216","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1841330/000121390024019216/ownership.xml","form_type":"4"}}]}